Luda B. Diatchenko
Luda B. Diatchenko publishes mostly in Physiology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Pain Mechanisms and Treatments, Fibromyalgia and Chronic Fatigue Syndrome Research and Temporomandibular Joint Disorders.
- World rank
- #126,685 of 7,710,434 ranked researchers
- Rank in United States
- #48,119 of 1,627,098
- Works
- 318
- Citations
- 23k
- Citations per work
- 72.4
What does Luda B. Diatchenko research?
Luda B. Diatchenko's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (20%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else13843.3%
- Health Sciences9429.5%
- Medicine9429.5%
- Life Sciences8627.2%
- 1Physiology18% of their works
- 2Molecular Biology15% of their works
- 3Cellular and Molecular Neuroscience7% of their works
- 4Psychiatry and Mental health6% of their works
- 5Pharmacology5% of their works
- 6Genetics5% of their works
Research topics
- Pain Mechanisms and Treatments
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Temporomandibular Joint Disorders
- Neuropeptides and Animal Physiology
- Musculoskeletal pain and rehabilitation
- Pain Management and Placebo Effect
- Receptor Mechanisms and Signaling
- Botulinum Toxin and Related Neurological Disorders
Which keywords describe Luda B. Diatchenko's research?
The keywords of their largest research topics: Central Sensitization, Chronic Pain, Neuropathic Pain, Nociception, Epidemiology, Psychological Factors, Diagnostic Criteria and Treatment.
- G-Protein-Coupled Receptors
- Botulinum Toxin
- Nocebo
- Disability
- Neuropeptides
- Bruxism
- Chronic Fatigue Syndrome
- Treatment
- Psychological Factors
- Nociception
- Chronic Pain
- Central Sensitization
- Neuropathic Pain
- Epidemiology
- Diagnostic Criteria
- Clinical Trials
- Fibromyalgia
- Temporomandibular Disorders
- Receptors
- Global Burden
- Placebo
- Crystal Structure
- Neurotoxins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Central Sensitization1582 topics
- Chronic Pain1472 topics
- Neuropathic Pain1171 topic
- Nociception1171 topic
- Epidemiology1093 topics
- Psychological Factors1093 topics
- Diagnostic Criteria792 topics
- Treatment582 topics
- Clinical Trials492 topics
- Chronic Fatigue Syndrome411 topic
- Fibromyalgia411 topic
- Bruxism381 topic
- Temporomandibular Disorders381 topic
- Neuropeptides311 topic
- Receptors311 topic
- Disability301 topic
- Global Burden301 topic
- Nocebo191 topic
- Placebo191 topic
- Botulinum Toxin171 topic
- Crystal Structure171 topic
- G-Protein-Coupled Receptors171 topic
- Neurotoxins171 topic
Where does Luda B. Diatchenko work?
Luda B. Diatchenko's main affiliation in the publication record is University of North Carolina at Chapel Hill, United States.
How many publications and citations does Luda B. Diatchenko have?
OpenAlex counts 318 works and 23,023 citations for Luda B. Diatchenko, an h-index of 70, ranking #126,685 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luda B. Diatchenko. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.